HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Total serum transforming growth factor-β1 is elevated in the entire spectrum of genetic aortic syndromes.

AbstractBACKGROUND:
Total serum transforming growth factor-beta 1 (tsTGF-β1) is increased in patients with Marfan syndrome (MFS), but it has not been assessed in thoracic aortic aneurysm and dissection (TAAD), Loeys-Dietz syndrome (LDS), and bicuspid aortic valve disease (BAVD).
HYPOTHESIS:
tsTGF-β1 is increased in genetic aortic syndromes including TAAD, LDS, MFS, and BAVD.
METHODS:
We measured tsTGF-β1 and performed sequencing of the genes FBN1, TGFBR1, and TGFBR2 in 317 consecutive patients with suspected or known genetic aortic syndrome (167 men, 150 women; mean age 43 ± 14 years). TAAD was diagnosed in 20, LDS in 20, MFS in 128, and BAVD in 30 patients, and genetic aortic syndrome was excluded in 119 patients.
RESULTS:
Elevated tsTGF-β1 levels were associated with causative gene mutations (P = 0.008), genetic aortic syndrome (P = 0.009), and sporadic occurrence of genetic aortic syndrome (P = 0.048), whereas only genetic aortic syndrome qualified as an independent predictor of tsTGF-β1 (P = 0.001). The tsTGF-β1 levels were elevated in FBN1 and NOTCH1 mutations vs patients without mutations (both P = 0.004), and in NOTCH1 mutations vs ACTA2/MYH11 mutations (P = 0.015). Similarly, tsTGF-β1 levels were elevated in MFS (P = 0.003) and in BAVD (P = 0.006) vs patients without genetic aortic syndrome. In contrast to specific clinical features of MFS, FBN1 in-frame mutations (P = 0.019) were associated with increased tsTGF-β1 levels.
CONCLUSIONS:
tsTGF-β1 is elevated in the entire spectrum of genetic aortic syndromes. However, gradual differences in the increases of tsTGF-β1 levels may mirror different degrees of alteration of tsTGF-β1 signaling in different genetic aortic syndromes.
AuthorsMathias Hillebrand, Nathalie Millot, Sara Sheikhzadeh, Meike Rybczynski, Sabine Gerth, Tilo Kölbel, Britta Keyser, Kerstin Kutsche, Peter N Robinson, Jürgen Berger, Thomas S Mir, Tanja Zeller, Stefan Blankenberg, Yskert von Kodolitsch, Britta Goldmann
JournalClinical cardiology (Clin Cardiol) Vol. 37 Issue 11 Pg. 672-9 (Nov 2014) ISSN: 1932-8737 [Electronic] United States
PMID25113270 (Publication Type: Journal Article)
Copyright© 2014 Wiley Periodicals, Inc.
Chemical References
  • FBN1 protein, human
  • Fibrillin-1
  • Fibrillins
  • Microfilament Proteins
  • NOTCH1 protein, human
  • Receptor, Notch1
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
Topics
  • Adolescent
  • Adult
  • Aged
  • Aortic Aneurysm, Thoracic (blood, genetics)
  • Aortic Valve (abnormalities)
  • Bicuspid Aortic Valve Disease
  • Female
  • Fibrillin-1
  • Fibrillins
  • Heart Valve Diseases (blood, genetics)
  • Humans
  • Loeys-Dietz Syndrome (blood, genetics)
  • Male
  • Marfan Syndrome (blood, genetics)
  • Microfilament Proteins (genetics)
  • Middle Aged
  • Mutation
  • Receptor, Notch1 (genetics)
  • Transforming Growth Factor beta1 (blood)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: